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An all-inclusive and transparent view of a vascular
program’s direct impact on its health system
Nyali Taylor, MD, Joseph V. Lombardi, MD, Sandra Toddes, MHA, James Alexander, MD,
Jose Trani, MD, and Jeffrey Carpenter, MD, Camden, NJ
Objective:This study explores the fiduciary advantage of a Vascular Surgery program to an academic, tertiary care hospital.
Methods: This is a retrospective review of hospital (HealthQuest) and physician (IDX) billing databases from April 2009
to September 2010. We identified all patients interacting with Vascular Surgery (VS) to provide an overview of global
finances. Patients introduced solely by VS were identified to minimize confounding of the downstream effect. Outcome
measures obtained were revenue, average and total gross margin, relative value unit production, and service utilization.
Results: A total of 552 cases were identified demonstrating $13 million in revenue. This translated into a gross margin of
$5million. Examined per surgeon, VS was the most profitable, producing $1.6 million. Lower extremity amputation had
the highest average gross margin at $34,000. Notably, $8 million in direct cost is among the highest in the health system.
A total of 137 cases unique to VS generated $5million in total revenue. This patient subset made use of up to 29 physician
specialty services. General Medicine and Radiology were the most frequently utilized.
Conclusion: The overall profitability of a comprehensive vascular program is tremendously positive. This study verifies
that new vascular-specific referrals are a significant catalyst for revenue. (J Vasc Surg 2012;55:281-5.)
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IThe focus of specific health care delivery can vary
regionally, favoring certain service lines depending on the
demographic and payor mix. The goal of any institution,
however, is to reduce costs, maximize their most profitable
revenue streams, and balance a complete compliment of
heath care delivery. Despite controlling expenditures and
maintaining revenue, the percentage of hospitals with a
negative margin still increased across every hospital class.1
Nurturing a new program in such an environment can be a
daunting task, so how do we partner with our institutions
to maintain our collective financial viability? The role of any
given service line is to maximize throughput while main-
taining quality. Somewhere, health care systems and health
care providers intersect in the proverbial “sweet spot”
where the efforts of a service line translate into a healthy
bottom line for each other. The benefits of such a relation-
ship can feed into other services, resulting in an avalanche of
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eport describing the current environment states, “physi-
ians can attract patients needing high-cost services . . .
ringing in added revenue.”2 Within our institution, we
ypothesize that the Division of Vascular and Endovascular
urgery generates profit, translating into global success for
ur health system. The aim is to demonstrate how our
artnership fuels financial strength and added growth to
he division and ultimately the health care system.
ETHODS
This study is a retrospective review of a single, urban
ertiary care center’s hospital and physician billing data-
ases: HealthQuest (McKesson, San Francisco, Calif) and
DX (IDX Systems Corporation, Burlington, Vt), from
pril 2009 to September 2010. In IDX, we obtained the
nancial analysis of physician practices by identifying spe-
ialty and subspecialty groups. This was accomplished by
istilling the fiduciary hierarchy (specialty group, division,
illing area, physician, current procedural terminology
CPT] codes) to extract information to level of CPT data.
rom the HealthQuest (HQ) database, patient cases were
elected by major diagnostic categories (MDC)/diagnosis-
elated group (DRG), procedure provider, or primary di-
gnosis. We assigned DRGs to service and subservice lines.
ince IDX and HQ databases do not interface, linking the
DX clinical patient identifiers (CPI) to a service date
ermitted isolation of the corresponding hospital encoun-
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January 2012282 Taylor et alter in HQ. Market information for Southern New Jersey
was obtained through the database, MarketExpert (Thom-
son Reuters, New York, NY), which is designed to deter-
mine market share and patient destination as well as com-
pare average length of stay as a proxy for acuity. The queries
were based on inpatient encounters and residents of the
system’s primary or secondary service areas carrying a pri-
mary diagnosis (or international classification of diseases
[ICD]) code of 441.X, aortic aneurysm, and dissection.
In an attempt to control for downstream effect initiated
by other specialties, we deliberately chose encounters intro-
duced into the system by Vascular Surgery. Each CPI,
where Vascular Surgery generated a bill, was compiled
through IDX. Those CPIs were utilized to generate the
entire scope of physician billing activity. Any patient having
8 months of inactivity in the health system prior to having
his first encounter with our division was identified. Each
was classified as unique to the Division of Vascular and
Endovascular Surgery (VES). Unique CPIs were then
cross-referenced in the HQ hospital billing system to cap-
ture the hospital data. Trauma patients were excluded
because of the multidisciplinary nature of the population
and variability in payor mix, ensuring that they would not
be unique to VES. Unique CPIs for patients accessing
hospital-related services (inpatient and outpatient) were
captured and evaluated for the end points of interest:
revenue, direct cost, and specialty service utilization. Out-
patient services, such as ultrasound, computed tomography
scans, magnetic resonance imaging, phlebotomy, physical
therapy, etc were all inclusive of our margin calculations.
The hospital-related cases were identified by DRGs associ-
ated with vascular surgical procedures or diseases. The
DRGs were then placed in the following classifications:
amputation, cardiovascular, extracranial, peripheral vascu-
lar and venous disease. Venous disease was treated as an
outlier and excluded based on the small volume of cases.
Separately, revenue and gross margins were calculated
from all accounts that were paid and loaded into the ac-
counting system Avega (Medassets, Alpharetta, Ga) across
all of the premiere service lines in the health system, includ-
ing, Orthopedics, Neurosurgery, Division of Cardiology
(includes Electrophysiology, catheterization lab, Cardiol-
ogy, and Cardiac Surgery), General Surgery, and Vascular
Surgery. To further distinguish hospital services, DRG
weights were applied for fiscal year (FY) 2010 to the specific
codes used by VES from the same period. DRG weights are
published annually. Averages were calculated in a standard
fashion. The average DRG weights for other service lines
were made available by our finance department for compar-
ison.3 FY 2010 was used as the most current, thus the most
representative. To derive the general cost per patient-day,
our finance department used the Avega accounting system
for a statistical analysis of the expenses and revenue in the
general ledger. From this, the total cost for each patient
encounter was calculated and divided by the number of
total patient-days per year.
Relative value unit (RVU) production and full time
clinical physician (FTE) compliment from these service aines were also described. We compared each service line by
ospital gross margin (GM), RVU, and FTE. These data
ere standardized between groups by analyzing the GM
nd RVUs per FTE.
Revenue included patient payment, payor payment,
ad debt recovery, and charity care/miscellaneous alloca-
ions. Cost was calculated using the direct cost attributed to
he care of the individual patients such as ancillary staff,
edications, operating room time and equipment, and
ietary. Indirect costs, fixed and variable, represent overhead
nd allocations specific to maintaining the hospital (eg, general
dministration/finance, global capital expense, security, etc).
hese were not included as they do not directly reflect a
ervice’s impact on patient care; hence, net margin (gross
argin less indirect cost) was not calculated. The gross
argin is defined as revenue less direct cost, and it is used in
his analysis as a directionally accurate proxy for the net
argin. Average gross margin is defined as the gross margin
ivided by the number of discharges; used here as a method
o balance maturing and established programs.
ESULTS
Overview. The area served by our tertiary care center
s comprised of eight counties in Southern New Jersey.
hese counties range from a nine to 80-mile radius from
he hospital. We share this market with hospitals in both
outhern New Jersey and Eastern Pennsylvania. Generally,
ew Jersey has two-thirds of the market share, while Penn-
ylvania maintains one-third. Our hospital is third overall
ith 13% of the market share as determined by the Market
xpert application.
The hospital infrastructure is composed of a Siemens
Washington, DC) hybrid operating suite and two identical
nterventional radiology (IR) suites, shared IR technolo-
ists; and a comprehensive inventory that is predominantly
onsigned. In 2009, the division received a $1.5 million
ubsidy from the health system. These included support for
he vascular fellowship, resource staff for office and clinical
rials, marketing staff, all expenses relating to database
anagement, 3D workstations and software, and part of
ur nurse practitioner program.
Global hospital finances. In 2009, 552 CPIs billed
y the Division of VES generated $12,875,213 in hospital
evenue. The predominant payor is Medicare, providing
eimbursements for 59% of the cases and 61% of the gross
argin. The remaining 41% are paid for by managed care,
edicaid, charity care, and commercial sources (24%, 9%,
%, 2%, respectively). The VES payor mix mirrors that of
ur hospital in that Medicare is the principal payor. The
inance Department calculated a total cost to the hospital
f approximately $2600/patient-day. The proportion of
otal inpatient volume attributed to VES is only 3%. Yet, it
ielded 6% of the total gross margin. Direct costs specific to
he vascular service line, in 2009, were $7,764,694 for a
ross margin of $5,110,919.
To assess where vascular surgery stands in terms of
ervice line production, the gross margin was calculated for
ll inpatient subspecialty service lines and compared with
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Volume 55, Number 1 Taylor et al 283RVU production as well as full-time physician employee
(FTE) compliment (Table I). Four vascular surgeons pro-
duce 3.17 FTE units when adjusting for nonclinical respon-
sibilities. The certified registered nurse practitioners
(CRNP) bill, almost exclusively, through each surgeon, so
are not included in the calculation of FTE units. VES in our
institution produced the leading margin per FTE, and was
second to General Surgery in margin per RVU. The average
gross margin (service gross margin divided by number of
service discharges) for VES is $7198, which is fourth be-
hind Thoracic Surgery, General Surgery, and Neurosurgery
(Fig).
Looking more closely at the 5.1 million dollars in gross
margin, a component of the hospital revenue was derived
from 1800 invasive and noninvasive interventions and eval-
uations performed by the division of VES. These proce-
dures could be divided into one of eight DRG categories
(Table II). The categories that achieved the greatest aver-
age revenue and gross margin were lower extremity ampu-
tations, major CV procedures, and “other vascular proce-
dures.” Major CV procedures include aortic interventions
and “other vascular procedures” include endovascular in-
tervention on nonperipheral vessels.4 When comparing
DRG weight as a proxy for Medicare reimbursement, VES
is third highest in compensation as delineated in Table III.
“Spin-off” finances. The vascular service line’s im-
pact on other services was assessed using the complete
billing for 137 patients introduced solely by VES. Evaluat-
ing the utilization of both hospital and physician services
Table I. Overview of the global hospital margins by FTE
Cardiology General Surger
Hospital GM $23,617,768 $15,141,263
2009 RVU 150,131 59,242
Physician FTE 22.08 11.52
RVU/FTE 6713 6136
GM/RVU $157.31 $255.58
GM/FTE $1,069,645.29 $1,314,345.75
FTE, Full-time clinical physician; GM, gross margin; RVU, relative value un
Source: IDX (IDX Systems Corporation, Burlington, Vt).
Fig. Average gross margin by top five hospital-based specialty
services.over 18 months, those patients generated 397 hospital and h370 physician encounters. All patients underwent
ospital-based procedures. The hospital and physician en-
ounters involved 27 and 29 different specialties, respec-
ively. Among hospital encounters, medical specialties pre-
ominated: General Medicine (33%), Emergency Medicine
10%), and Cardiology (9%). Internal Medicine, Critical
are, Family Medicine, and Hospitalist services were
rouped for tabulation of hospital services. The physician
ncounters reveal Radiology as the dominant service line
ollowed by General Medicine and Nephrology (24%, 15%,
nd 14%, respectively). Internal Medicine, Critical Care,
nd Hospitalist services were grouped for tabulation of
ospital services.
Over 18 months, the revenue generated by vascular
atients naive to the health system totaled $5,348,279
Table IV). The influence of nonvascular services (spin-off)
otaled $3,622,053 in revenue with a gross margin of
1,594,316.
ISCUSSION
We have demonstrated the profitability of an academic
ascular program to a health system by direct surgeon
ontributions via clinical productivity. In an academic set-
ing, the requirements of clinical productivity have become
ncreasingly onerous due to poor payor mix, increasing
verhead and waning reimbursements, bolstering the need
o ramp up clinical volume in an effort to supplement
nancial deficits.2 Privately owned practices, without real-
zing a strong relationship with a health system, may find it
ncreasingly difficult to be self-sustaining in this climate.
he physician practices presented here are largely owned by
he health system except for several private groups. The
dvantage is an interconnected relationship where
he health system has a vested interest in the success of the
hysician groups and vice versa. Through continuous inter-
ctions, we found that collaboration with our health care
dministrators helped form trusting relationships and a
een understanding of each other’s role. Health system
esources, such as marketing, information technology, and
egal services all help with programmatic development.
ES was identified by the hospital administration as a “blue
hip” specialty with great potential for growth. The DRG
eight provides an approximation of the influence on
edicare reimbursement, which puts VES third among
VU for the top five service lines
Orthopedics Vascular Neurosurgery
$5,512,980 $5,110,918 $1,229,021
86,610 26,701 27,528
11.90 3.17 4.93
7732 8423 6726
$63.65 $191.41 $44.65
$463,275.63 $1,612,276 $249,294.32and R
y
it.ospital service lines. Evidenced by the gross margin and
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compares favorably among the top five programs in our
health system.
To measure all the programs collectively, we deter-
mined the value of each program per unit of work per-
formed by the physicians in each service line. The RVU
stands as the only measurable unit uniformly and conve-
niently utilized by all the physicians in our health system.
Overall, the health system gains $191 per Vascular RVU
generated, while physician billing receives approximately
$33. Based on the division’s profit and loss accounting, we
are able to supplement the vascular program with a bud-
geted $1.5 to $1.7 million hospital subsidy for nonclinical
requisites. Combined with the hospital gross margin, VES
is a viable and productive resource for the health system. In
addition, recognizing the value of the service in this way
encourages future development via programmatic cultiva-
tion, growth of vascular resources and services.
We also furnished a small glimpse of what “new” pa-
tients can generate to hospital and physician services via
spin-off finances. The focus of our institution is on cardio-
vascular services with VES benefiting from a robust cardiac
program. However, Vascular Surgery provides a reciprocal
benefit to these services, generating 3,370 physician and
397 hospital encounters from 137 patients new to the
division as well as the health system. With 50% of those
unique patients interacting with other specialties, we are
Table II. Sum of average revenue and average gross marg
DRG Description
239, 240, 241 Amp excluding upper limb
237, 238 Major CV procedures/TAAA
252, 253, 254 Other vascular procedures
255, 256, 257 Amp upper limb and toe
37, 38, 39 Extracranial procedures
264 Other circ system procedures
35, 36 CAS
299, 300, 301 PVD
CAS, Carotid artery stent; CV, cardiovascular; DRG, diagnosis-related grou
Source: HQ (McKesson, San Francisco, Calif).
Table III. Average DRG weight by service line for
hospital-based services
Service line
Current % of
inpatient volume
Average 2010
DRG weight
General surgery 8% 3.53
Div of Cardiology 26% 2.24
Vascular surgery 6% 2.22
Orthopedics 5% 1.88
Oncology 16% 1.68
Neurosciences 10% 1.50
Digestive health 14% 1.42
General medicine 15% 1.02
System total 100% 1.87
DRG, Diagnosis-related group.creating a stable revenue stream, especially for our most srequently utilized services: Medicine, Cardiology, and Ra-
iology. Nonvascular services contributed 66% of the gross
argin in this group. Third-party payers impact our finan-
ial status significantly as Medicare is the dominant payer
nd may provide a more reliable source of income. How-
ver, it is a double-edged sword since it also serves as the
enchmark by which other insurers determine their reim-
ursement scales. In the face of receding compensation, we
re going to truly require hospital support to maintain
uality services.
The Vascular division has a full complement of re-
ources designed for patient safety, continued clinical
rowth, and fulfilling our mission of education. Hospital
upport allows the division to implement a robust nurse
ractitioner program for inpatient and outpatient services.
hrough this program we have standardized care pathways
or all patient procedures and provided vital education to
ospital nursing staff on the management of vascular pa-
ients. Overall, these quality control initiatives have main-
ained a low mean length of stay with concomitant dou-
ling of our inpatient volume over the past two years,
ranslating into both savings and revenue.
The ability of a service line to generate revenue is a fairly
traightforward measurement; however, cost determina-
ions pose a challenge. Although we were unable to quan-
ify indirect costs, our annual direct cost is among the
ighest of all specialty hospital service lines. Despite this,
ES was the fourth-highest average gross margin. The data
s sobering as it demonstrates that expenditure control will
e key to improving our margin further. Understanding
ur high cost profile establishes the need for vigilant survey
nd modifications of our revenue cycle, especially in the
ace of new Medicare regulations.4 Although our group has
aken several steps already, especially with documentation
or coding and decreasing denials; cost containment still
emains a challenge. We cannot manipulate indirect costs
uch as hospital overhead. One way to achieve this may be
o consider the creation of an interdisciplinary vascular
enter within the hospital to share some of those costs,
educing the burden on any one division. Another ap-
roach is to reform the behavior affecting our own costs.
edicare recognizes that the swell in its cost correlates to
he volume of testing and studies performed, which is not
DRG
Average revenue ($) Average gross margin ($)
80,786 34,066
67,891 24,757
52,645 22,610
45,560 18,789
41,533 18,252
28,118 14,779
28,189 11,489
25,944 9408
D, peripheral vascular disease; TAAA, thoracoabdominal aortic aneurysm.in by
p; PVustainable at this rate.5 This means that Medicare will
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down effect with other third-party payers.6 It is in our best
interest to prove that we can manage this within our health
systems without federal restrictions further impacting our
options.
Limitations. Our study was limited in several ways.
We had a very small sample over a relatively short period of
time, which was not representative of the complete com-
plement of patients treated at our hospital. Only patient
accounts that were completely adjudicated were used
within the given time period. A more robust sample size
for spin-off calculation would be more representative
and minimize selection bias. Another limitation was that
indirect costs were not measured to calculate net mar-
gins. The analysis of the VES service line’s procedures
was generated from DRG vs ICD-9 codes. This may
skew the outcome related to profitability of a given
procedure type. Although we used DRG weights as a
proxy for the case mix index (CMI), CMI was not
included in our original analysis; hence, missing an im-
portant aspect of VES impact on revenue via Medicare. A
picture of how the health system handles such costs can
be important to future program development.
CONCLUSION
In summary, we have demonstrated an estimated value
of our Division of VES to our health system. A complex
relationship with multiple stakeholders, from the patients
to the payors, exerts an effect on the benchmarks used to
make that assessment. We have learned that despite our
division’s size and patient volume, we are capable of gen-
erating a strong gross margin. There is literature supporting
hospital administrations’ need to understand the strength
of specialty services, the impact of a sound relationship, and
the benefit of increasing recruitment efforts for specialty
services.1 VES also acts as a feeder system to as many as 30
other specialty services to support significant revenue gen-
eration for the hospital. In isolation, VES would have
significant difficulty maintaining the resources necessary for
Table IV. Financial overview rendered by 137 vascular-sp
Count of account
number
Sum of tot
amo
Hospital billing
Vascular surgery 163 $9,14
Nonvascular surgery 397 $14,63
Hospital total 560 $23,77
Physician billing
Vascular surgery 771 $1,86
Nonvascular surgery 3370 $1,73
Physician total 4141 $3,59
Grand total 4701 $27,37
Sources: HQ (McKesson, San Francisco, Calif) and IDX (IDX Systems Cora growing academic practice. Partnership with the health System has allowed us to increase productivity, achieve
rogrammatic growth, educate and enhance quality. Ef-
orts such as improved documentation and standardized
linical care pathways by the clinical nurse practitioners are
ecognized measures for improving reimbursements.5
owever, our future focus will require finding innovative
ays to provide effective, efficient, and safe care economi-
ally.
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